share_log

Universe Pharmaceuticals | 20-F: FY2022 Annual Report

SEC ·  Feb 11, 2023 05:56
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more